Cargando…
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
BACKGROUND: High-throughput screening (HTS) is one of the main strategies to identify novel entry points for the development of small molecule chemical probes and drugs and is now commonly accessible to public sector research. Large amounts of data generated in HTS campaigns are submitted to public...
Autores principales: | Visser, Ubbo, Abeyruwan, Saminda, Vempati, Uma, Smith, Robin P, Lemmon, Vance, Schürer, Stephan C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149580/ https://www.ncbi.nlm.nih.gov/pubmed/21702939 http://dx.doi.org/10.1186/1471-2105-12-257 |
Ejemplares similares
-
Formalization, Annotation and Analysis of Diverse Drug and Probe Screening Assay Datasets Using the BioAssay Ontology (BAO)
por: Vempati, Uma D., et al.
Publicado: (2012) -
Evolving BioAssay Ontology (BAO): modularization, integration and applications
por: Abeyruwan, Saminda, et al.
Publicado: (2014) -
Facilitating transparency in spinal cord injury studies using data standards and ontologies
por: Lemmon, Vance P., et al.
Publicado: (2014) -
Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation
por: Clark, Alex M., et al.
Publicado: (2014) -
An extension of the BioAssay Ontology to include pharmacokinetic/pharmacodynamic terminology for the enrichment of scientific workflows
por: Penn, Steve, et al.
Publicado: (2023)